Abstract -Introduction : The increasing number of traffic deaths related to the use of drugs of abuse has made indispensable the use of roadside tests in an easy and fast way. The test most commonly used in Spain is the immunoassaybased Cozart RapiScan Oral Fluid Drug Testing System. Due to the great number of analysis, it has become essential to validate this test by using more sensible methods. Accordingly, a test validation that combines analysis by gas chromatography and detection by mass spectrometry (GC-MS/MS) has been considered. Methods: The total number of samples examined in this study includes 216 cases collected on the road by traffic police and analyzed by a roadside test. Positive samples were confirmed by GC-MS/MS. Results: Among the 216 cases examined with the oral fluid test, 155 cases were positive and 61 were negative. In the analysis carried out by using GC-MS/MS, 158 were positive and 58 were negative. Conclusion: The results supports the reliability of the oral fluid test as a method for the detection of narcotic substances in situ, though later confirmation is recommended using a more sensitive method.
Introduction
In the last years there has been an increasing number of studies dealing with the detection of drugs in biological fluids and particularly with the detection of people driving under the effects of drugs (DUID) or alcohol [1, 2] . The importance of these studies stems from the necessity to minimize the deaths caused by the consumption of alcohol and drugs by the driver. In this context the availability of reliable and accurate Correspondence: M. Sánchez, masanchezf@xij.gencat.net roadside tests has become increasingly important. The urgent need for having reliable detection tests has been clearly recognized since the 1990s by both police and legislators [3] [4] [5] , and accordingly different matrixes have been evaluated [6] [7] [8] .
Among the earliest studies, oral fluid (OF) test has been considered as a valuable procedure to be used on-site by police officers.
OF is a complex biological matrix consisting not only of the products generated by the secretary glands (parotid, submandibular and sublingual) that form saliva, but also Article published by EDP Sciences from secretions produced by minor glands (labial, buccal and palatal) as well as other substances such as bacteria, food debris, epithelial cells and gingival fluid [9] [10] [11] . The concentration of drugs in OF depends on the relative contribution of each gland since the transportation of drugs from plasma to saliva involves passive diffusion across lipid membranes, and different factors related to the chemical structure and nature of drugs play important roles in this mechanism [11] [12] [13] .
Once OF was considered as a matrix in drug testing, its use has rapidly increased primarily due to the advantages that collection of samples from OF offers in comparison with other biological matrixes, such as blood and urine. The main advantages are the possibility of collection by non-medical personnel, the non-invasive character of this procedure and the difficulty to adulterate the sample [14] . These advantages have made OF to be a particularly promising matrix among the possible kinds of matrixes used in toxicological laboratories. Therefore, it is not surprising that the number of publications related to detection of drugs using OF samples has increased since 1980, leading to the development of devices aimed at the screening of abuse drugs such as amphetamines, cocaine, opiates (morphine and codeine) and cannabinoids [15, 16] .
The aim of this study is to validate the roadside test most commonly used in Spain, which relies on an immunoassay test performed on OF samples. Due to the large number of analyses carried out in the last years, there is an urgent need to validate the reliability of this test by resorting to the comparison with more sensible, accurate methods. In fact, this is motivated by the fact that the analytes identified by the immunoassaybased OF test are Δ 9 -THC, 6-monoacetylmorphine, cocaine, amphetamine and methamphetamine with cut-off values of 31 ng/mL for Δ 9 -THC, 30 ng/mL for cocaine and 50 ng/mL for 6-acetylmorphine, methamphetamine and amphetamine. The technique used to validate the immunoassay-based OF test was gas chromatography and detection by mass spectrometry (GC-MS/MS), which has been extensively used for the analysis of a wide range of drugs after suitable derivatization [17] .
Observations
To 216 cases collected on the road by traffic police and analyzed by the roadside test Cozart RapiScan Oral Fluid Drug Testing System. Positive samples were duplicated, for later confirmation. There was not a duplicate from all of the negative samples due to the legal impossibility to obtain a sample when the OF test was negative and the driver assent was not obtained.
Materials and methods
Chemicals and materials. Methanol solutions with a concentration of 1 mg/mL of cocaine, Δ 9 -tetrahydrocannabinol (Δ 9 -THC), amphetamine, methamphetamine, dl-3, 4-methylendioximethamphetamine (dl-3, 4-MDMA), dl-3, 4-methylendioxiethampheta-mine (dl-3, 4-MDEA) and 6-monoacetylmorphine (6-MAM) were purchased from Alltech-Applied Science (State College, PA, USA). For derivatization of Oral fluid samples. A total of 216 OF samples were obtained in roadside tests carried out by the police. Police officers were asked to collect sample in duplicate (one for roadside test and another for laboratory analysis) in those cases where the driver seemed to be under the effect of narcotic substances. One of the samples was analyzed in situ by using the Cozart RapiScan Oral Fluid Drug Testing System in order to detect the possible consumption of drugs, and the duplicated sample was collected spitting in a plastic tube and stored at 4
• C to be analyzed in the laboratory with the GC-MS/MS technique.
Sample preparation. Sample preparation consisted of the addition of 1 mL oral fluid to 1 mL phosphate buffer (pH = 6). Once the pH was readjusted, 20 µL of d3-cocaine, d3-6-MAM, d5-amphetamine, d9-methamphetamine and d9-Δ 9 -THC were added for a final concentration of 10 µg/mL [18] . The sample was transferred in a Toxitube A , stirred by using an orbital stirrer (in order to mix the immiscible phases) for 10 min and centrifuged (3500 rpm for 10 min). The organic phase was extracted, evaporated to dryness under nitrogen and derivatized with 40 µL of BSFTA-TMCS at 80
• C for 20 min for Δ 9 -THC and 6-MAM or PFPA for amphetamines and methamphetamines at 50
• C for 40 min.
GC-MS/MS conditions.
A Varian Inc. (Palo Alto, USA) 3800 gas chromatograph coupled to a 4000 mass selective ion trap detector (MSD) operating in electron impact mode was used for analysis (GC-MS/MS). The gas chromatographic column was 5% phenyl-95% methyl silicone DB-5, 0.25 mm ID, 0.25 µm thickness, 30 m length (Varian factorFour Capillary Column) and the injection temperature was 250 • C. 2 µL of the sample were injected in splitless mode. The oven was programmed from 90
• C for 1 min; ramped at 20
• C/min up to 240
• C; then ramped at 5
• C/min to 300 • C where it remained for two minutes. The transfer line was held at 280
• C. The total run time was 23.5 min. Detection was performed operating in MS/MS. Details of the detection procedure are shown in Table I , and the different substances and ions identified by MS/MS are shown in Table II . The MS/MS spectrums from the standards of the studied drugs are shown in Figure 1 .
Limit of detection-Limit of quantification (LOD-LOQ).
Since cut-offs for the roadside OF test were different from the LOD and LOQ values used in the GC-MS/MS confirmation, OF test cut-offs and LOD and LOQ for GC-MS/MS are shown in Table III .
Results
Among the 216 cases analyzed by using the oral fluid test, a total of 155 cases were positive and 61 were negative (Table IV GC-MS/MS as positive and 3 were false positive, and from the 61 negative samples only 19 were confirmed by GC-MS/MS, from which 6 were positive, all of them to cannabis. Thus, in the analysis by GC-MS/MS 158 cases were positive and 58 were negative (Table V) .
Based on these results, it can be stated that both methods are in agreement for 98.1% of the positive cases, but only 68.4% of the negatives ones.
Discussion
This work examines the reliability of commercial and available devices for the detection of drugs in OF samples. The importance of this subject is supported by the large number of studies referred to commercial tests and the correlation with analytical methods in order to achieve higher detection levels of drugs in OF samples. The results obtained here indicate that positive cases can be detected confidently by the OF test. However, the random sampling of 19 negatives cases of the immunoassay-based test showed a 31.6% of false negatives, which would raise the total number of positive cases to cannabinoids. The difficulty associated with the detection of the different metabolites of cannabis is well-known [19, 20] , and this fact should be taken into account in order to approve the immunoassay-based OF test for routine roadside tests.
The reliability of the OF test is supported by the large agreement (>95%) found with the results obtained from a highly sensitive method such as GC/MS-MS. This test, nevertheless, should be rejected for the analysis of Δ 9 -THC, since it gives rise to an error of ca. 30% in negative samples for cannabis, although all the available kits show similar results for Δ 9 -THC and the error is also minimized by the fact that all of them are false negatives instead of false positives.
Overall, the OF test can be considered to be a valid method for the detection of narcotic substances in situ, which also combines a short analysis time and a practical, easy procedure to collect samples. However, confirmation by more sensible methods is recommended to detect drugs at lower concentrations [21] [22] [23] . Furthermore, it would be strongly recommended the use of both drug tests and ethilometers in road preventive controls. 
